MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 68 filers reported holding MEIRAGTX HLDGS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $409,456 | -22.5% | 62,800 | 0.0% | 0.00% | – |
| Q3 2022 | $528,000 | +11.2% | 62,800 | 0.0% | 0.00% | – |
| Q2 2022 | $475,000 | -34.8% | 62,800 | +19.4% | 0.00% | – |
| Q1 2022 | $729,000 | -37.1% | 52,600 | +7.8% | 0.00% | -100.0% |
| Q4 2021 | $1,159,000 | +84.0% | 48,800 | +2.1% | 0.00% | – |
| Q3 2021 | $630,000 | -15.0% | 47,800 | 0.0% | 0.00% | – |
| Q2 2021 | $741,000 | +3.9% | 47,800 | -3.2% | 0.00% | – |
| Q1 2021 | $713,000 | -4.7% | 49,400 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $748,000 | +69.2% | 49,400 | +47.9% | 0.00% | – |
| Q3 2020 | $442,000 | +5.7% | 33,400 | 0.0% | 0.00% | – |
| Q2 2020 | $418,000 | +11.2% | 33,400 | +19.3% | 0.00% | – |
| Q1 2020 | $376,000 | -33.0% | 28,000 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $561,000 | +41.7% | 28,000 | +12.9% | 0.00% | – |
| Q3 2019 | $396,000 | -40.6% | 24,800 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $667,000 | – | 24,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
| Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
| Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
| Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
| Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
| 683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
| Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
| Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
| PA Capital LLC | 39,039 | $525,000 | 0.46% |